Sarcopenia indicates a loss of skeletal muscle mass, a condition that leads to a decline in
physical performance. In 2018, the European Working Group on Sarcopenia in Older People …

Opportunistic CT screening leverages robust imaging data embedded within abdominal and
thoracic scans that are generally unrelated to the specific clinical indication and have …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

Recently, sarcopenia has garnered renewed interest. Sarcopenia is a disease characterized
by decreased skeletal muscle mass and strength/function, which can impair the quality of life …

Abstract Background/Objective: There is increasing use of computed tomography (CT) in
sarcopenia research using a wide variety of techniques. We performed a systematic review …

Patients with cancer are at particularly high risk for malnutrition because both the disease
and its treatments threaten their nutritional status. Yet cancer-related nutritional risk is …

The radiological assessment of muscle properties—size, mass, density (also termed
radiodensity), composition, and adipose tissue infiltration—is fundamental in muscle …

Reductions in muscle mass and strength are well known complications of advancing age. All
muscles of the body are affected, including those critical to chewing and swallowing. A …

Objective: To evaluate preoperative body composition, including skeletal muscle and
visceral adipose tissue, and to clarify the impact on outcomes after hepatectomy for …

The associations between sarcopenia and metabolic syndrome (MetS) in non-obese middle-
aged and older adults remain controversial. Thus, this meta-analysis aimed to evaluate the …